The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
In the ongoing fight against cancer, Technion breakthroughs in diagnostics and treatments have improved and saved lives around the world. This year alone, scientists at the Rappaport Technion Integrated Cancer Center (RTICC) have advanced research on early detection of various cancers, curbing cancer metastasis, and personalized treatment.
RTICC donors enjoyed an exclusive look at the cutting-edge work they were instrumental in promoting.
Panelists discussed:
There was a 15-minute Q&A session following the discussion.
The webinar was moderated by Sara Crown Star, a member of the Crown family of Chicago, prominent supporters of the RTICC.
Associate Professor Asya Rolls heads a lab in the Rappaport Faculty of Medicine that investigates the physiological mechanisms whereby emotions and thoughts affect health. For example, her laboratory showed that the release of the “feel-good neurotransmitter” dopamine disabled tumor-promoting cells in the immune system of mice, allowing them to fight cancer.
Professor Irit Ben-Aharon is director of the Division of Oncology at Rambam Health Care Campus, which is affiliated with the Technion and is the largest cancer center in northern Israel. She earned her M.D. and Ph.D. at a joint program of Tel Aviv University and the National Institutes of Health. Her research focuses on the toxic effects of chemotherapy on fertility, and on the fetus during pregnancy.
